• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Formulation and Characterization of Transdermal Patches of Diclofenac

Formulation and Characterization of Transdermal Patches of Diclofenac

Paperback

Medical Reference

Currently unavailable to order

ISBN10: 3659112585
ISBN13: 9783659112584
Publisher: Lap Lambert Academic Pub
Published: Jul 27 2012
Pages: 140
Weight: 0.47
Height: 0.33 Width: 6.00 Depth: 9.00
Language: English
The purpose of this research was to develop a matrix-type transdermal therapeutic system containing Diclofenac acid (DA), Pressure Sensitive Adhesive (PSA) by the solvent evaporation technique. Different concentrations of Labrasol, oleic acid and triacetin were used to enhance the transdermal permeation of DA. Polyethylene monolayer film as a backing membrane and Silicone coated polyester film as a release liner preferred in preparation of transdermal patches. Formulated transdermal patches were physically evaluated with regard to percentage moisture absorption, thickness, weight variation, drug content, tensile strength, % elongation, folding endurance. In vitro skin permeation studies of formulations were performed by using Franz diffusion cells. Formulation containing 5% drug, 85% adhesive and 10% triacetin as permeation enhancer showed best in vitro skin permeation through human cadaver skin as compared to all other formulations. The results were found to follow zero order kinetics. These results indicate that optimized formulation has shown optimum release in concentration independent manner.

Also in

Medical Reference